LobbyingProlacta Bioscience lobbying by quarter
Prolacta Bioscience's latest lobbying report covers Q2 2026, at $150K. The four quarters Q4 2025–Q3 2026 total $450K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Budget/Appropriations.
Prolacta Bioscience
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $450K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $80K | 1 |
| Q1 2023 | $60K | 1 |
| Q2 2023 | $60K | 1 |
| Q3 2023 | $60K | 1 |
| Q4 2023 | $60K | 1 |
| Q1 2024 | $60K | 1 |
| Q2 2024 | $60K | 1 |
| Q3 2024 | $150K | 2 |
| Q4 2024 | $150K | 2 |
| Q1 2025 | $150K | 2 |
| Q2 2025 | $150K | 2 |
| Q3 2025 | $150K | 2 |
| Q4 2025 | $150K | 2 |
| Q1 2026 | $150K | 2 |
| Q2 2026 | $150K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$1M · 23 reports
- Budget and appropriations$306.7K · 15 reports
- Food industry$306.7K · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES23 reports
- SENATE23 reports
- Centers For Medicare and Medicaid Services (CMS)8 reports
- Food & Drug Administration (FDA)8 reports
- Health & Human Services, Dept of (HHS)8 reports
- White House Office7 reports
Firms it paid
| Firm | ||
|---|---|---|
| Tremont Strategies Group | $920K | 15 quarters |
| BGR Government Affairs | $720K | 8 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| DANIEL FARMER | Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack Space | Q2 2026 |
| JAMES WILLIAMS | Special Assist. to the Pres., WH Domestic Policy Council, 2019-2021; Economist, WH Council of Economic Advisors, 2017-2019 | Q2 2026 |
| JOHN STONE | Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C | Q2 2026 |
| REMY LEIGH BRIM MASON | Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz | Q2 2026 |
| ROBB WALTON | Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. Nunes | Q1 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | BGR Government Affairs | $90K |
| 07/20for Q2 | Tremont Strategies Group | $60K |
| 04/20for Q1 | Tremont Strategies Group | $60K |
| 04/20for Q1 | BGR Government Affairs | $90K |
| 01/20for Q4 2025 | BGR Government Affairs | $90K |
| 01/20for Q4 2025 | Tremont Strategies Group | $60K |
| 25/10/20for Q3 2025 | BGR Government Affairs | $90K |
| 25/10/20for Q3 2025 | BGR Government Affairs | $90K |
| 25/10/20for Q3 2025 | Tremont Strategies Group | $60K |
| 25/07/21for Q2 2025 | Tremont Strategies Group | $60K |
| 25/07/21for Q2 2025 | BGR Government Affairs | $90K |
| 25/04/21for Q1 2025 | Tremont Strategies Group | $60K |
| 25/04/21for Q1 2025 | BGR Government Affairs | $90K |
| 25/01/21for Q4 2024 | Tremont Strategies Group | $60K |
| 25/01/20for Q4 2024 | BGR Government Affairs | $90K |
| 24/10/21for Q3 2024 | BGR Government Affairs | $90K |
| 24/10/21for Q3 2024 | Tremont Strategies Group | $60K |
| 24/09/05for Q3 2024 | BGR Government Affairs | Under $5,000 |
| 24/07/22for Q2 2024 | Tremont Strategies Group | $60K |
| 24/04/22for Q1 2024 | Tremont Strategies Group | $60K |